HUE025513T2 - TNF-alfával kapcsolatos rendellenességek kezelése - Google Patents
TNF-alfával kapcsolatos rendellenességek kezeléseInfo
- Publication number
- HUE025513T2 HUE025513T2 HUE10742811A HUE10742811A HUE025513T2 HU E025513 T2 HUE025513 T2 HU E025513T2 HU E10742811 A HUE10742811 A HU E10742811A HU E10742811 A HUE10742811 A HU E10742811A HU E025513 T2 HUE025513 T2 HU E025513T2
- Authority
- HU
- Hungary
- Prior art keywords
- scd
- pyridazin
- inhibitors
- ones
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/22—Nitrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0955504A FR2948939B1 (fr) | 2009-08-05 | 2009-08-05 | Derives de 2h pyridazin-3-ones, leur preparation et leur application en therapeutique humaine |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE025513T2 true HUE025513T2 (hu) | 2016-05-30 |
Family
ID=41582079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE10742811A HUE025513T2 (hu) | 2009-08-05 | 2010-08-05 | TNF-alfával kapcsolatos rendellenességek kezelése |
Country Status (10)
Country | Link |
---|---|
US (1) | US8946225B2 (zh) |
EP (1) | EP2462121B1 (zh) |
JP (1) | JP5901520B2 (zh) |
AR (1) | AR077715A1 (zh) |
ES (1) | ES2536841T3 (zh) |
FR (1) | FR2948939B1 (zh) |
HU (1) | HUE025513T2 (zh) |
PL (1) | PL2462121T3 (zh) |
TW (1) | TW201109313A (zh) |
WO (1) | WO2011015629A1 (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR086113A1 (es) | 2011-04-30 | 2013-11-20 | Abbott Lab | Isoxazolinas como agentes terapeuticos |
WO2013056148A2 (en) * | 2011-10-15 | 2013-04-18 | Genentech, Inc. | Methods of using scd1 antagonists |
WO2013085957A1 (en) * | 2011-12-06 | 2013-06-13 | Janssen Pharmaceutica Nv | Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors |
WO2013085954A1 (en) | 2011-12-06 | 2013-06-13 | Janssen Pharmaceutica Nv | Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors |
CN108026182B (zh) | 2015-09-18 | 2022-04-26 | 国立大学法人宫崎大学 | 长效肾上腺髓质素衍生物 |
WO2018081167A1 (en) | 2016-10-24 | 2018-05-03 | Yumanity Therapeutics | Compounds and uses thereof |
BR112019013954A2 (pt) | 2017-01-06 | 2020-02-11 | Yumanity Therapeutics, Inc. | Métodos para o tratamento de distúrbios neurológicos |
CA3083000A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
EA202192047A1 (ru) * | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0412343A (pt) * | 2003-07-30 | 2006-09-05 | Xenon Pharmaceuticals Inc | derivados de piridazina e seu uso como agentes terapêuticos |
US7759348B2 (en) | 2003-07-30 | 2010-07-20 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
RU2339381C2 (ru) * | 2004-02-09 | 2008-11-27 | Ниссан Кемикал Индастриз, Лтд. | Ингибитор гиперплазии интимы сосудов |
EP1966183A4 (en) * | 2005-12-20 | 2010-12-29 | Merck Frosst Canada Ltd | HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A-DELTA-9-DESATURASE |
JP4984701B2 (ja) * | 2006-07-18 | 2012-07-25 | 富士ゼロックス株式会社 | Ledプリントヘッドの製造方法 |
JP4695565B2 (ja) * | 2006-08-21 | 2011-06-08 | 株式会社リコー | 画像形成装置 |
EP2065369A4 (en) * | 2006-08-23 | 2011-12-28 | Astellas Pharma Inc | UREA CONNECTION OR SALT THEREOF |
WO2008044767A1 (fr) * | 2006-10-13 | 2008-04-17 | Takeda Pharmaceutical Company Limited | Dérivé d'amine aromatique et utilisation de celui-ci |
MX2010001485A (es) | 2007-08-08 | 2010-06-01 | Graceway Pharmaceuticals Llc | Derivado de fenoxi-pirrolidina y su uso, y composiciones. |
-
2009
- 2009-08-05 FR FR0955504A patent/FR2948939B1/fr not_active Expired - Fee Related
-
2010
- 2010-07-28 TW TW099124897A patent/TW201109313A/zh unknown
- 2010-08-05 HU HUE10742811A patent/HUE025513T2/hu unknown
- 2010-08-05 WO PCT/EP2010/061426 patent/WO2011015629A1/en active Application Filing
- 2010-08-05 US US13/388,884 patent/US8946225B2/en active Active
- 2010-08-05 ES ES10742811.2T patent/ES2536841T3/es active Active
- 2010-08-05 PL PL10742811T patent/PL2462121T3/pl unknown
- 2010-08-05 AR ARP100102874A patent/AR077715A1/es unknown
- 2010-08-05 JP JP2012523342A patent/JP5901520B2/ja active Active
- 2010-08-05 EP EP10742811.2A patent/EP2462121B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP5901520B2 (ja) | 2016-04-13 |
ES2536841T3 (es) | 2015-05-29 |
EP2462121A1 (en) | 2012-06-13 |
EP2462121B1 (en) | 2015-02-18 |
PL2462121T3 (pl) | 2015-07-31 |
FR2948939B1 (fr) | 2013-03-22 |
WO2011015629A1 (en) | 2011-02-10 |
US8946225B2 (en) | 2015-02-03 |
TW201109313A (en) | 2011-03-16 |
AR077715A1 (es) | 2011-09-14 |
US20120178678A1 (en) | 2012-07-12 |
FR2948939A1 (fr) | 2011-02-11 |
JP2013501031A (ja) | 2013-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20150477T8 (hr) | Postupci dobivanja derivata kinazolona | |
HUE025513T2 (hu) | TNF-alfával kapcsolatos rendellenességek kezelése | |
HK1194071A1 (zh) | 某些三唑並吡嗪、其組合物及其用法 | |
HK1164050A1 (zh) | 取代的偶氮蒽衍生物、藥物組合物及其使用方法 | |
AP3179A (en) | Benzofuranyl derivatives used as glucokinase inhibitors | |
IL215251A0 (en) | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use | |
SG10201405568UA (en) | 4-substituted pyridin-3-yl-carboxamide compounds and methods of use | |
IL236830A0 (en) | Diazahomoredene derivatives and methods of using them | |
HRP20130538T1 (en) | Therapeutic uses of quinazolinedione derivatives | |
IL248077B (en) | Formulations, salts and polymers of transnorsertraline and their uses | |
EP2490541A4 (en) | 2-SUBSTITUTED ETHYL HYLTHIAZONE DERIVATIVES AND THEIR USE | |
IL214408A0 (en) | Derivatives of 6-(6-substituted-triazolopyidazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors | |
EP2424533A4 (en) | SUBSTITUTED ISOQUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE AS-SECRETASE INHIBITORS | |
AP2013006816A0 (en) | Ptocess for preparing pan-CDK inhibitors of the formula (I), and intermediates in the preparation | |
GB0908609D0 (en) | New use of isoQC inhibitors | |
HU0900647D0 (en) | Salts of 7-nitroindoline derivatives and use thereof | |
PL389364A1 (pl) | Nowe zastosowanie pochodnych 2-pirolidonu |